Allspring Global Investments Holdings, LLC

Position in JANX — Janux Therapeutics, Inc.

CIK 1890906 CHARLOTTE, NC

Position in JANX

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$2,348,766

+$2,142,151 QoQ

Shares Held

168,976

+1898.8% QoQ

Ownership

0.277%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 27% Shared 0% None 73%

Healthcare · as of Mar 31, 2026

Allspring Global Investments Holdings, LLC holds $702,720,315 across 64 Biotechnology names. JANX ranks #26 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	175,311	$128,020,857
2	ALNY	Alnylam Pharmaceuticals, Inc.	281,793	$93,236,848
3	EXEL	Exelixis, Inc.	1,707,715	$73,243,895
4	BBIO	BridgeBio Pharma, Inc.	889,356	$66,043,575
5	VRTX	Vertex Pharmaceuticals Inc / Ma	123,760	$55,263,790
6	INSM	INSMED Inc	282,734	$46,232,662
7	ASND	Ascendis Pharma A/S	184,224	$42,137,554
8	REGN	Regeneron Pharmaceuticals, Inc.	52,497	$40,561,281

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,348,766	168,976	+1898.8%	Shares	Defined	2026-05-05
2025-09-30	$206,615	8,454	-6.4%	Shares	Defined	2025-10-20
2025-03-31	$243,891	9,033	+54.0%	Shares	Defined	2025-04-24
2024-12-31	$314,012	5,865	+0.2%	Shares	Defined	2025-01-29
2024-09-30	$265,810	5,851	-6.9%	Shares	Defined	2024-10-18
2024-06-30	$263,236	6,284	-1.0%	Shares	Defined	2024-07-26
2024-03-31	$239,039	6,349	-75.8%	Shares	Defined	2024-04-29
2023-12-31	$281,812	26,264	+2166.1%	Shares	Defined	2024-01-25
2023-09-30	$11,682	1,159	-78.4%	Shares	Defined	2023-10-27
2022-03-31	$76,819	5,357	0.0%	Shares	Defined	2022-04-27
2021-12-31	$105,693	5,357	—	Shares	Defined	2022-01-28
No filing history on record for this holder in this stock.